|
DE2947526A1
(de)
|
1978-11-29 |
1980-06-12 |
Ono Pharmaceutical Co |
Prostacyclin-analoge
|
|
US4668814A
(en)
|
1984-03-08 |
1987-05-26 |
The Upjohn Company |
Interphenylene carbacyclin derivatives
|
|
JPS61289034A
(ja)
|
1985-06-17 |
1986-12-19 |
Teijin Ltd |
イソカルバサイクリン類脂肪乳剤
|
|
US4837342A
(en)
|
1986-02-28 |
1989-06-06 |
Sagami Chemical Research Center |
Prostacyclin analogue, and blood circulation improving agent and anti-ulcer composition containing it as active ingredient
|
|
GB8814438D0
(en)
|
1988-06-17 |
1988-07-20 |
Wellcome Found |
Compounds for use in medicine
|
|
GB9011588D0
(en)
|
1990-05-24 |
1990-07-11 |
Wellcome Found |
Prostaglandin analogues for use in medicine
|
|
US6165500A
(en)
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
|
CA2056039A1
(en)
|
1991-01-22 |
1992-07-23 |
Philip L. Fuchs |
Carbacyclin analogs
|
|
US5190972A
(en)
|
1992-01-27 |
1993-03-02 |
The University Of Melbourne |
Method of combatting cyclosporine organ toxicity with prostaglandin analogs
|
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
|
US5576016A
(en)
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
|
US6638621B2
(en)
|
2000-08-16 |
2003-10-28 |
Lyotropic Therapeutics, Inc. |
Coated particles, methods of making and using
|
|
US6441245B1
(en)
|
1997-10-24 |
2002-08-27 |
United Therapeutics Corporation |
Process for stereoselective synthesis of prostacyclin derivatives
|
|
AU1373499A
(en)
|
1997-11-14 |
1999-06-07 |
United Therapeutics Corporation |
Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
|
|
AU742250B2
(en)
|
1997-12-26 |
2001-12-20 |
Astellas Pharma Inc. |
Sustained release medicinal compositions
|
|
JP2002521423A
(ja)
|
1998-07-31 |
2002-07-16 |
コリア インスティチュート オブ サイエンス アンド テクノロージ |
遺伝子又は薬物運搬体としての脂質エマルジョン及び固形脂質微粒子
|
|
US6265495B1
(en)
*
|
1998-09-22 |
2001-07-24 |
Nippon Shokubai Co., Ltd. |
Method for production of esterified product
|
|
US6521212B1
(en)
|
1999-03-18 |
2003-02-18 |
United Therapeutics Corporation |
Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
|
|
AU4327300A
(en)
|
1999-03-31 |
2000-10-16 |
United Therapeutics Corporation |
Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension
|
|
US6242482B1
(en)
|
2000-06-05 |
2001-06-05 |
United Therapeutics Corporation |
Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure
|
|
US6306435B1
(en)
|
2000-06-26 |
2001-10-23 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
|
|
EP1408932A4
(en)
|
2001-06-23 |
2009-02-25 |
Lyotropic Therapeutics Inc |
PARTICLES WITH ENHANCED SOLUBILIZATION CAPACITY
|
|
US20030108512A1
(en)
|
2001-12-10 |
2003-06-12 |
Robert Shorr |
Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer
|
|
US6803386B2
(en)
|
2002-01-16 |
2004-10-12 |
United Therapeutics Corporation |
Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
|
|
WO2004012680A2
(en)
|
2002-08-06 |
2004-02-12 |
Lyotropic Therapeutics, Inc. |
Lipid-drug complexes in reversed liquid and liquid crystalline phases
|
|
EP1628641A2
(en)
|
2003-05-19 |
2006-03-01 |
Baxter International Inc. |
Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers
|
|
ATE341312T1
(de)
|
2003-05-20 |
2006-10-15 |
Ethypharm Sa |
Orale pharmazeutische zusammensetzung mit verzögerter freisetzung
|
|
WO2005007081A2
(en)
|
2003-05-22 |
2005-01-27 |
United Therapeutics Corporation |
Compounds and methods for delivery of prostacyclin analogs
|
|
ES2331187T3
(es)
|
2003-12-16 |
2009-12-23 |
United Therapeutics Corporation |
Utilizacion de treprostinil para mejorar las funciones renales.
|
|
DE602004028155D1
(de)
|
2003-12-16 |
2010-08-26 |
United Therapeutics Corp |
Verwendung von treprostinil zur behandlung von ischämischen läsionen
|
|
CN101287457B
(zh)
|
2004-04-12 |
2011-11-16 |
联合治疗公司 |
Treprostinil用于治疗神经性糖尿病的足部溃疡的用途
|
|
GB0416328D0
(en)
|
2004-07-21 |
2004-08-25 |
Univ Cardiff |
Use of dry powder compositions for pulmonary delivery
|
|
CA2574958A1
(en)
|
2004-07-26 |
2006-02-09 |
Cotherix, Inc. |
Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
|
|
JP4893999B2
(ja)
|
2004-10-22 |
2012-03-07 |
小野薬品工業株式会社 |
吸入用医薬組成物
|
|
EP1973523A2
(en)
|
2005-12-15 |
2008-10-01 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
WO2007134292A2
(en)
|
2006-05-15 |
2007-11-22 |
United Therapeutics Corporation |
Treprostinil administration using a metered dose inhaler
|
|
WO2008049000A2
(en)
|
2006-10-18 |
2008-04-24 |
United Therapeutics Corporation |
Combination therapy for pulmonary arterial hypertension
|
|
CN101678033A
(zh)
|
2007-02-09 |
2010-03-24 |
联合治疗公司 |
用于间质性肺病和哮喘的曲前列尼治疗
|
|
JP2010523595A
(ja)
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
ポリ（アミノ酸）ターゲッティング部分
|
|
ES2562669T3
(es)
|
2007-09-07 |
2016-03-07 |
United Therapeutics Corporation |
Soluciones de tampón con una actividad bactericida selectiva contra bacterias Gram negativas y métodos para usarlas
|
|
EP2252570B1
(en)
|
2007-12-17 |
2017-04-05 |
United Therapeutics Corporation |
An improved process to prepare treprostinil, the active ingredient in remodulin ®
|
|
WO2009137066A1
(en)
|
2008-05-08 |
2009-11-12 |
United Therapeutics Corporation |
Treprostinil monohydrate
|
|
WO2009152160A1
(en)
|
2008-06-10 |
2009-12-17 |
Gilead Sciences, Inc. |
Inhaled carbaprostacyclin and prostacyclin prodrugs for the treatment of pulmonary arterial hypertension
|
|
WO2009158010A1
(en)
|
2008-06-27 |
2009-12-30 |
Concert Pharmaceuticals, Inc. |
Prostacyclin analogs
|
|
WO2010039531A1
(en)
|
2008-09-23 |
2010-04-08 |
Resolvyx Pharmaceuticals, Inc. |
Therapeutic compounds
|
|
EP2330893A4
(en)
|
2008-09-25 |
2013-01-09 |
Aradigm Corp |
DEEP PULMONARY ADMINISTRATION OF TREPROSTINIL
|
|
EP2398443A2
(en)
|
2009-02-20 |
2011-12-28 |
Micro Labs Limited |
Storage stable prostaglandin product
|
|
CN102421288B
(zh)
|
2009-05-07 |
2015-04-22 |
联合治疗公司 |
前列环素类似物的固体剂型
|
|
WO2011005505A2
(en)
|
2009-06-22 |
2011-01-13 |
Johnson Matthey Public Limited Company |
Method for the purification of prostaglandins
|
|
US20120270934A1
(en)
|
2009-07-03 |
2012-10-25 |
Concert Pharmaceuticals, Inc. |
Prostacyclin derivatives
|
|
ES2451790T3
(es)
|
2009-08-07 |
2014-03-28 |
Scipharm Sàrl |
Composición para el tratamiento de la fibrosis quística
|
|
SG178502A1
(en)
|
2009-08-21 |
2012-03-29 |
Targeted Delivery Technologies Ltd |
Vesicular formulations
|
|
CN101669904B
(zh)
|
2009-09-29 |
2011-06-22 |
北京中海康医药科技发展有限公司 |
一种依前列醇脂质纳米粒及制备方法
|
|
US20130030359A1
(en)
|
2010-01-22 |
2013-01-31 |
Ascendis Pharma A/S |
Dipeptide-based prodrug linkers for aromatic amine-containing drugs
|
|
US9062094B2
(en)
|
2010-01-22 |
2015-06-23 |
Ascendis Pharma As |
Dipeptide-based prodrug linkers for aliphatic amine-containing drugs
|
|
ES2611187T3
(es)
|
2010-03-15 |
2017-05-05 |
United Therapeutics Corporation |
Tratamiento para hipertensión pulmonar
|
|
EP2576492B1
(en)
|
2010-06-03 |
2017-09-20 |
United Therapeutics Corporation |
Treprostinil production
|
|
WO2011159693A2
(en)
|
2010-06-15 |
2011-12-22 |
United Therapeutics Corporation |
Oral treatment of digital ischemic lesions
|
|
US20120010159A1
(en)
|
2010-07-09 |
2012-01-12 |
United Therapeutics Corporation |
Combination therapies with cox-2 inhibitors and treprostinil
|
|
CA2710726C
(en)
|
2010-07-22 |
2016-02-23 |
Alphora Research Inc. |
Synthesis of treprostinil and intermediates useful therein
|
|
WO2012107364A1
(en)
|
2011-02-07 |
2012-08-16 |
Scipharm Sàrl |
Novel composition for the treatment of cystic fibrosis
|
|
JP5780775B2
(ja)
|
2011-02-18 |
2015-09-16 |
株式会社Ｌｔｔバイオファーマ |
プロスタグランジンｉ２誘導体を含有するナノ粒子
|
|
EP2681204B1
(en)
|
2011-03-02 |
2016-04-27 |
United Therapeutics Corporation |
Synthesis of intermediate for treprostinil production
|
|
US9532950B2
(en)
|
2011-03-14 |
2017-01-03 |
National University Corporation Hokkaido University |
Vector for pulmonary delivery, inducing agent, and uses
|
|
JP6092867B2
(ja)
|
2011-08-12 |
2017-03-08 |
アセンディス ファーマ エー／エス |
担体連結しているトレプロスチニルプロドラッグ
|
|
MX2014001496A
(es)
|
2011-08-12 |
2014-04-30 |
Ascendis Pharma As |
Composicion de liberacion sostenida de prostaciclina.
|
|
US20140249093A1
(en)
|
2011-08-12 |
2014-09-04 |
Ascendis Pharma A/S |
Carrier-Linked Prodrugs Having Reversible Carboxylic Ester Linkages
|
|
US20140323402A1
(en)
|
2011-08-12 |
2014-10-30 |
Ascendis Phama A/S |
Protein Carrier-Linked Prodrugs
|
|
WO2013024048A1
(en)
|
2011-08-12 |
2013-02-21 |
Ascendis Pharma A/S |
Polymeric hyperbranched carrier-linked prodrugs
|
|
EP2741779A1
(en)
|
2011-08-12 |
2014-06-18 |
Ascendis Pharma A/S |
High-loading water-soluble carrier-linked prodrugs
|
|
US8524939B2
(en)
|
2011-08-24 |
2013-09-03 |
Chirogate International Inc. |
Intermediates for the synthesis of benzindene prostaglandins and preparations thereof
|
|
US9387214B2
(en)
|
2012-01-13 |
2016-07-12 |
United Therapeutics Corporation |
Method of identifying therapies for pulmonary hypertension
|
|
PL2674413T3
(pl)
|
2012-06-15 |
2018-05-30 |
Scipharm Sàrl |
Sposób wytwarzania treprostynilu i jego pochodnych
|
|
ES2713988T3
(es)
|
2012-08-01 |
2019-05-24 |
United Therapeutics Corp |
Tratamiento de hipertensión arterial pulmonar con células progenitoras endoteliales tratadas con prostaciclina
|
|
EP2879682B1
(en)
|
2012-08-01 |
2018-03-21 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
|
|
CN104822372A
(zh)
|
2012-11-30 |
2015-08-05 |
英斯梅德股份有限公司 |
前列环素组合物及其使用方法
|
|
ES2963968T3
(es)
|
2013-01-09 |
2024-04-03 |
United Therapeutics Corp |
Tratamiento de la vasculopatía con prostaciclina y células madre mesenquimatosas
|
|
US9371264B2
(en)
*
|
2013-01-11 |
2016-06-21 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
|
CN105164098A
(zh)
|
2013-03-14 |
2015-12-16 |
联合治疗公司 |
曲前列环素的固体形式
|
|
JP2016516693A
(ja)
|
2013-03-15 |
2016-06-09 |
ユナイテッド セラピューティクス コーポレイション |
トレプロスチニルの塩
|
|
CN105228451B
(zh)
|
2013-03-25 |
2018-03-30 |
联合治疗公司 |
制备具有硫醇连接子和聚乙二醇化形式的前列环素化合物的方法
|
|
CN105407883A
(zh)
|
2013-04-30 |
2016-03-16 |
联合治疗学有限公司 |
控释药物制剂
|
|
WO2014203278A2
(en)
|
2013-06-19 |
2014-12-24 |
Msn Laboratories Private Limited |
NOVEL PROCESS FOR THE PREPARATION OF (1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-HEXAHYDRO-2-HYDROXY-1-[(3S)-3-HYDROXYOCTYL]-1H-BENZ[f]INDEN-5-YL]OXY]ACETIC ACID
|
|
EP3054937B1
(en)
|
2013-10-11 |
2023-07-26 |
Pulmokine, Inc. |
Spray dry formulations
|
|
PL3060041T3
(pl)
|
2013-10-25 |
2021-08-02 |
Insmed Incorporated |
Związki prostacykliny
|
|
WO2015138423A1
(en)
|
2014-03-11 |
2015-09-17 |
Insmed Incorporated |
Prostacylin compositions and methods for using the same
|
|
AU2015274377B2
(en)
|
2014-06-13 |
2020-07-23 |
United Therapeutics Corporation |
Treprostinil formulations
|
|
EP3209415B1
(en)
|
2014-10-20 |
2020-02-19 |
United Therapeutics Corporation |
Synthesis of intermediates for producing prostacyclin derivatives
|
|
ES2873873T3
(es)
|
2014-11-18 |
2021-11-04 |
Insmed Inc |
Métodos de fabricación de treprostinilo y profármacos derivados de treprostinilo
|
|
US20160318844A1
(en)
|
2015-04-29 |
2016-11-03 |
Insmed Incorporated |
Prostacyclin compounds, compositions and methods of use thereof
|
|
IL319790A
(en)
|
2016-05-05 |
2025-05-01 |
Liquidia Tech Inc |
Terpostinil in dry powder form for the treatment of pulmonary hypertension
|
|
WO2017223400A1
(en)
|
2016-06-24 |
2017-12-28 |
Insmed Incorporated |
Prostacyclin compounds and compositions for treating sarcoidosis
|
|
EP3515430A1
(en)
|
2016-09-26 |
2019-07-31 |
United Therapeutics Corporation |
Treprostinil prodrugs
|
|
EP3673895A1
(en)
|
2018-12-28 |
2020-07-01 |
Université Libre de Bruxelles |
Dry powder inhalation formulation and its use for the therapeutic treatment of lungs
|
|
JP7455144B2
(ja)
|
2019-04-29 |
2024-03-25 |
インスメッド インコーポレイテッド |
トレプロスチニルプロドラッグの乾燥粉末組成物およびその使用方法
|